Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Multiple Sclerosis

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

woman deeply breathing on a white couch

Brief Biofeedback Protocol Improves Stress and Mood Outcomes in Multiple Sclerosis

Study shows short-term behavioral training can yield objective and subjective gains

young man using walking canes on a city street

Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons

Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

physician talking with a patient in medical office

De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor

Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug

Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

two brain MRIs side by side with red circles on them

Cognitive Impairment in Multiple Sclerosis Linked to Rapid Thalamic Atrophy

Machine learning study associates discrete neuropsychological testing profiles with neurodegeneration

two brain MRIs side by side

Brain Volume Changes and Disability in MOGAD: Defining Differences From Other Demyelinating Diseases

Despite less overall volume loss than in MS and NMOSD, volumetric changes correlate with functional decline

two brain MRIs with red arrows indicating spots of interest

Paramagnetic Rim Lesions Are Highly Accurate for MS Diagnosis at First Presentation

This MRI marker of inflammation can help differentiate MS from mimics early in the disease

BackPage 1 of 6Next

Advertisement

Ad